MBX Biosciences, Inc. (MBX) reporting calendar
MBX Biosciences, Inc. files periodic reports with the SEC as MBX on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 19 Jul 2026 – 26 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open MBX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-210593 |
| 10-K | 31 Dec 2025 | 12 Mar 2026 | 71 days | 0001193125-26-103121 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001193125-25-268148 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0000950170-25-104619 |
| 10-Q | 31 Mar 2025 | 12 May 2025 | 42 days | 0000950170-25-068602 |
| 10-K | 31 Dec 2024 | 17 Mar 2025 | 76 days | 0000950170-25-039838 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-122840 |
Source: SEC EDGAR company submissions for CIK 0001776111. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.